Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 1366 AL 1380

A scoping review on medication adherence in older patients with cognitive impairment or dementia

Hudani ZK, Rojas-Fernandez CH.

Res Social Adm Pharm. 2016 Nov-Dec;12(6):815-829. doi: 10.1016/j.sapharm.2015.11.011. Epub 2015 Dec 2.

Dietary Patterns and Risk of Dementia: a Systematic Review and Meta-Analysis of Cohort Studies

Cao L, Tan L, Wang HF, Jiang T, Zhu XC, Lu H, Tan MS, Yu JT.

Mol Neurobiol. 2016 Nov;53(9):6144-6154. doi: 10.1007/s12035-015-9516-4. Epub 2015 Nov 9.

Tannoid principles of Emblica officinalis renovate cognitive deficits and attenuate amyloid pathologies against aluminum chloride induced rat model of Alzheimer's disease

Justin Thenmozhi A, Dhivyabharathi M, William Raja TR, Manivasagam T, Essa MM.

Nutr Neurosci. 2016 Jul;19(6):269-78. doi: 10.1179/1476830515Y.0000000016. Epub 2015 Apr 4.

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

Siemers ER, Sundell KL, Carlson C, Case M, Sethuraman G, Liu-Seifert H, Dowsett SA, Pontecorvo MJ, Dean RA, Demattos R.

Alzheimers Dement. 2016 Feb;12(2):110-120. doi: 10.1016/j.jalz.2015.06.1893. Epub 2015 Aug 1.

Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease

Alexopoulos P, Roesler J, Thierjung N, Werle L, Buck D, Yakushev I, Gleixner L, Kagerbauer S, Ortner M, Grimmer T, Kübler H, Martin J, Laskaris N, Kurz A, Perneczky R.

Eur Arch Psychiatry Clin Neurosci. 2016 Oct;266(7):587-97. doi: 10.1007/s00406-015-0628-7. Epub 2015 Aug 8.

Neuroproteomic profiling of human body fluids

Häggmark A, Schwenk JM, Nilsson P.

Proteomics Clin Appl. 2016 Apr;10(4):485-502. doi: 10.1002/prca.201500065. Epub 2015 Oct 12.

Differential Atrophy of Hippocampal Subfields: A Comparative Study of Dementia with Lewy Bodies and Alzheimer Disease

Mak E, Su L, Williams GB, Watson R, Firbank M, Blamire A, O'Brien J.

Am J Geriatr Psychiatry. 2016 Feb;24(2):136-43. doi: 10.1016/j.jagp.2015.06.006. Epub 2015 Jun 25.

Neprilysin Confers Genetic Susceptibility to Alzheimer's Disease in Han Chinese

Wang HZ, Bi R, Zhang DF, Li GD, Ma XH, Fang Y, Li T, Zhang C, Yao YG.

Mol Neurobiol. 2016 Sep;53(7):4883-92. doi: 10.1007/s12035-015-9411-z. Epub 2015 Sep 11.

The role of cerebrovascular disease when there is concomitant Alzheimer disease

Vemuri P, Knopman DS.

Biochim Biophys Acta. 2016 May;1862(5):952-6. doi: 10.1016/j.bbadis.2015.09.013. Epub 2015 Sep 25.

Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk

Ebbert MTW, Boehme KL, Wadsworth ME, Staley LA; Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Disease Genetics Consortium; Mukherjee S, Crane PK, Ridge PG, Kauwe JSK.

Alzheimers Dement. 2016 Feb;12(2):121-129. doi: 10.1016/j.jalz.2015.08.163. Epub 2015 Oct 9.

Lowered Levels of Carbonyl Proteins after Vitamin B Supplementation in Patients with Mild Cognitive Impairment and Alzheimer's Disease

Rommer PS, Fuchs D, Leblhuber F, Schroth R, Greilberger M, Tafeit E, Greilberger J.

Neurodegener Dis. 2016;16(3-4):284-9. doi: 10.1159/000441565. Epub 2015 Nov 21.

Is amyloid-β harmful to the brain? Insights from human imaging studies

Jagust W.

Brain. 2016 Jan;139(Pt 1):23-30. doi: 10.1093/brain/awv326. Epub 2015 Nov 27.

Alzheimer's disease lymphocytes: potential for biomarkers?

Wojda U.

Biomark Med. 2016;10(1):1-4. doi: 10.2217/bmm.15.79. Epub 2015 Dec 7.

Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field

Shams S, Wahlund LO.

Biomark Med. 2016;10(1):9-18. doi: 10.2217/bmm.15.101. Epub 2015 Dec 7.

Paradigm shift: semantic memory decline as a biomarker of preclinical Alzheimer's disease

Venneri A, Mitolo M, De Marco M.

Biomark Med. 2016;10(1):5-8. doi: 10.2217/bmm.15.53. Epub 2015 Dec 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias